Hungary

Gedeon Richter has entered a collaboration agreement with Indian firm Astron Research to develop and expand the Hungarian firm's portfolio of generic drugs. Richter claims the deal... 2010-03-26

BMI has introduced greater clarity to its core views for the Pharmaceuticals & Healthcare. Short-term core views concern the period through to the end of the 2011-2013 patent cliff,... 2010-03-15

The presence of countries from BMI's Emerging Europe Region in the Pharmaceutical Research and Manufacturers of America (PhRMA)'s Special 301 Submission 2010 remains largely equivalent... 2010-03-11

Hungarian generics firm Egis has acquired distribution rights for biosimilar products from South Korean biotechnology company Celltrion across markets in Central and Eastern Europe... 2010-02-12

Hungary is highly-ranked with regard to health expenditure in Central and Eastern Europe (CEE). Of the 20 countries measured by BMI, the country ranks fourth on a per-capita basis,... 2010-01-20

Israel-based generic drugmaker Teva is to invest over EUR65mn (US$93mn) in a new manufacturing plant in Hungary. The Israeli firm's 15,000 square-metre plant, to be located in Gödöllő,... 2010-01-18

BMI considers Hungary's reimbursement system to be fairly restrictive compared to other markets in Central and Eastern Europe, particularly from an industry perspective. Although... 2010-01-15